世界のヒト凝固第VIII因子市場予測 2020年-2025年

【英語タイトル】Global Human Coagulation Factor VIII Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP4206)・商品コード:LPI20AP4206
・発行会社(調査会社):LP Information
・発行日:2020年3月27日(※2024年版があります。お問い合わせください)
・ページ数:166
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「ヒト凝固第VIII因子の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、組換え第VIII因子、血漿由来第VIII因子など、用途別には、血友病A、自発性/外傷、外科、その他などに区分してまとめた調査レポートです。ヒト凝固第VIII因子のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・ヒト凝固第VIII因子の世界市場概要(サマリー)
・ヒト凝固第VIII因子の企業別販売量・売上
・ヒト凝固第VIII因子の企業別市場シェア
・ヒト凝固第VIII因子の世界市場規模 2015年-2020年:種類別(組換え第VIII因子、血漿由来第VIII因子)
・ヒト凝固第VIII因子の世界市場規模 2015年-2020年:用途別(血友病A、自発性/外傷、外科、その他)
・ヒト凝固第VIII因子の米州市場規模(アメリカ、カナダ、メキシコなど)
・ヒト凝固第VIII因子のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ヒト凝固第VIII因子の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒト凝固第VIII因子の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒト凝固第VIII因子市場の成長要因・課題・動向
・ヒト凝固第VIII因子の世界市場予測 2021年-2025年
・ヒト凝固第VIII因子の米州市場予測(アメリカ、カナダ、メキシコなど)
・ヒト凝固第VIII因子のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ヒト凝固第VIII因子の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒト凝固第VIII因子の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒト凝固第VIII因子の世界市場予測:種類別(組換え第VIII因子、血漿由来第VIII因子)
・ヒト凝固第VIII因子の世界市場予測:用途別(血友病A、自発性/外傷、外科、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Human Coagulation Factor VIII market will register a 3.1% CAGR in terms of revenue, the global market size will reach $ 8748.2 million by 2025, from $ 7738.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Coagulation Factor VIII business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor VIII market by type, application, key manufacturers and key regions and countries.

This study considers the Human Coagulation Factor VIII value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Recombinant Factor VIII
Plasma-derived Factor VIII

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hemophilia A
Spontanous / Trauma
Surgical
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Shire (Baxter)
Kedrion
Bayer
Pfizer
Grifols
CSL
NovoNordisk
Biogen
Greencross
Octapharma
BPL
RAAS
Hualan Bio

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Human Coagulation Factor VIII consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human Coagulation Factor VIII market by identifying its various subsegments.
Focuses on the key global Human Coagulation Factor VIII manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Coagulation Factor VIII with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Coagulation Factor VIII submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Coagulation Factor VIII Consumption 2015-2025
2.1.2 Human Coagulation Factor VIII Consumption CAGR by Region
2.2 Human Coagulation Factor VIII Segment by Type
2.2.1 Recombinant Factor VIII
2.2.2 Plasma-derived Factor VIII
2.3 Human Coagulation Factor VIII Consumption by Type
2.3.1 Global Human Coagulation Factor VIII Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Coagulation Factor VIII Sale Price by Type (2015-2020)
2.4 Human Coagulation Factor VIII Segment by Application
2.4.1 Hemophilia A
2.4.2 Spontanous / Trauma
2.4.3 Surgical
2.4.4 Other
2.5 Human Coagulation Factor VIII Consumption by Application
2.5.1 Global Human Coagulation Factor VIII Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Coagulation Factor VIII Value and Market Share by Type (2015-2020)
2.5.3 Global Human Coagulation Factor VIII Sale Price by Type (2015-2020)

3 Global Human Coagulation Factor VIII by Company
3.1 Global Human Coagulation Factor VIII Sales Market Share by Company
3.1.1 Global Human Coagulation Factor VIII Sales by Company (2018-2020)
3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Company (2018-2020)
3.2 Global Human Coagulation Factor VIII Revenue Market Share by Company
3.2.1 Global Human Coagulation Factor VIII Revenue by Company (2018-2020)
3.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Company (2018-2020)
3.3 Global Human Coagulation Factor VIII Sale Price by Company
3.4 Global Human Coagulation Factor VIII Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Coagulation Factor VIII Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Coagulation Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Human Coagulation Factor VIII by Regions
4.1 Human Coagulation Factor VIII by Regions
4.2 Americas Human Coagulation Factor VIII Consumption Growth
4.3 APAC Human Coagulation Factor VIII Consumption Growth
4.4 Europe Human Coagulation Factor VIII Consumption Growth
4.5 Middle East & Africa Human Coagulation Factor VIII Consumption Growth

5 Americas
5.1 Americas Human Coagulation Factor VIII Consumption by Countries
5.1.1 Americas Human Coagulation Factor VIII Consumption by Countries (2015-2020)
5.1.2 Americas Human Coagulation Factor VIII Value by Countries (2015-2020)
5.2 Americas Human Coagulation Factor VIII Consumption by Type
5.3 Americas Human Coagulation Factor VIII Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Human Coagulation Factor VIII Consumption by Regions
6.1.1 APAC Human Coagulation Factor VIII Consumption by Regions (2015-2020)
6.1.2 APAC Human Coagulation Factor VIII Value by Regions (2015-2020)
6.2 APAC Human Coagulation Factor VIII Consumption by Type
6.3 APAC Human Coagulation Factor VIII Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Human Coagulation Factor VIII by Countries
7.1.1 Europe Human Coagulation Factor VIII Consumption by Countries (2015-2020)
7.1.2 Europe Human Coagulation Factor VIII Value by Countries (2015-2020)
7.2 Europe Human Coagulation Factor VIII Consumption by Type
7.3 Europe Human Coagulation Factor VIII Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Human Coagulation Factor VIII by Countries
8.1.1 Middle East & Africa Human Coagulation Factor VIII Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Coagulation Factor VIII Value by Countries (2015-2020)
8.2 Middle East & Africa Human Coagulation Factor VIII Consumption by Type
8.3 Middle East & Africa Human Coagulation Factor VIII Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Coagulation Factor VIII Distributors
10.3 Human Coagulation Factor VIII Customer

11 Global Human Coagulation Factor VIII Market Forecast
11.1 Global Human Coagulation Factor VIII Consumption Forecast (2021-2025)
11.2 Global Human Coagulation Factor VIII Forecast by Regions
11.2.1 Global Human Coagulation Factor VIII Forecast by Regions (2021-2025)
11.2.2 Global Human Coagulation Factor VIII Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Coagulation Factor VIII Forecast by Type
11.8 Global Human Coagulation Factor VIII Forecast by Application

12 Key Players Analysis
12.1 Shire (Baxter)
12.1.1 Company Information
12.1.2 Human Coagulation Factor VIII Product Offered
12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Shire (Baxter) Latest Developments
12.2 Kedrion
12.2.1 Company Information
12.2.2 Human Coagulation Factor VIII Product Offered
12.2.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Kedrion Latest Developments
12.3 Bayer
12.3.1 Company Information
12.3.2 Human Coagulation Factor VIII Product Offered
12.3.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bayer Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Human Coagulation Factor VIII Product Offered
12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Grifols
12.5.1 Company Information
12.5.2 Human Coagulation Factor VIII Product Offered
12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Grifols Latest Developments
12.6 CSL
12.6.1 Company Information
12.6.2 Human Coagulation Factor VIII Product Offered
12.6.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 CSL Latest Developments
12.7 NovoNordisk
12.7.1 Company Information
12.7.2 Human Coagulation Factor VIII Product Offered
12.7.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 NovoNordisk Latest Developments
12.8 Biogen
12.8.1 Company Information
12.8.2 Human Coagulation Factor VIII Product Offered
12.8.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Biogen Latest Developments
12.9 Greencross
12.9.1 Company Information
12.9.2 Human Coagulation Factor VIII Product Offered
12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Greencross Latest Developments
12.10 Octapharma
12.10.1 Company Information
12.10.2 Human Coagulation Factor VIII Product Offered
12.10.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Octapharma Latest Developments
12.11 BPL
12.11.1 Company Information
12.11.2 Human Coagulation Factor VIII Product Offered
12.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 BPL Latest Developments
12.12 RAAS
12.12.1 Company Information
12.12.2 Human Coagulation Factor VIII Product Offered
12.12.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 RAAS Latest Developments
12.13 Hualan Bio
12.13.1 Company Information
12.13.2 Human Coagulation Factor VIII Product Offered
12.13.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Hualan Bio Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Human Coagulation Factor VIII Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Recombinant Factor VIII
Table 5. Major Players of Plasma-derived Factor VIII
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Human Coagulation Factor VIII Consumption Market Share by Type (2015-2020)
Table 8. Global Human Coagulation Factor VIII Revenue by Type (2015-2020) ($ million)
Table 9. Global Human Coagulation Factor VIII Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Human Coagulation Factor VIII Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Human Coagulation Factor VIII Consumption Market Share by Application (2015-2020)
Table 13. Global Human Coagulation Factor VIII Value by Application (2015-2020)
Table 14. Global Human Coagulation Factor VIII Value Market Share by Application (2015-2020)
Table 15. Global Human Coagulation Factor VIII Sale Price by Application (2015-2020)
Table 16. Global Human Coagulation Factor VIII Sales by Company (2017-2019) (Kg)
Table 17. Global Human Coagulation Factor VIII Sales Market Share by Company (2017-2019)
Table 18. Global Human Coagulation Factor VIII Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Human Coagulation Factor VIII Revenue Market Share by Company (2017-2019)
Table 20. Global Human Coagulation Factor VIII Sale Price by Company (2017-2019)
Table 21. Global Human Coagulation Factor VIII Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Human Coagulation Factor VIII Products Offered
Table 23. Human Coagulation Factor VIII Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Human Coagulation Factor VIII Consumption by Regions 2015-2020 (Kg)
Table 25. Global Human Coagulation Factor VIII Consumption Market Share by Regions 2015-2020
Table 26. Global Human Coagulation Factor VIII Value by Regions 2015-2020 ($ Millions)
Table 27. Global Human Coagulation Factor VIII Value Market Share by Regions 2015-2020
Table 28. Americas Human Coagulation Factor VIII Consumption by Countries (2015-2020) (Kg)
Table 29. Americas Human Coagulation Factor VIII Consumption Market Share by Countries (2015-2020)
Table 30. Americas Human Coagulation Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Human Coagulation Factor VIII Value Market Share by Countries (2015-2020)
Table 32. Americas Human Coagulation Factor VIII Consumption by Type (2015-2020) (Kg)
Table 33. Americas Human Coagulation Factor VIII Consumption Market Share by Type (2015-2020)
Table 34. Americas Human Coagulation Factor VIII Consumption by Application (2015-2020) (Kg)
Table 35. Americas Human Coagulation Factor VIII Consumption Market Share by Application (2015-2020)
Table 36. APAC Human Coagulation Factor VIII Consumption by Countries (2015-2020) (Kg)
Table 37. APAC Human Coagulation Factor VIII Consumption Market Share by Countries (2015-2020)
Table 38. APAC Human Coagulation Factor VIII Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Human Coagulation Factor VIII Value Market Share by Regions (2015-2020)
Table 40. APAC Human Coagulation Factor VIII Consumption by Type (2015-2020) (Kg)
Table 41. APAC Human Coagulation Factor VIII Consumption Market Share by Type (2015-2020)
Table 42. APAC Human Coagulation Factor VIII Consumption by Application (2015-2020) (Kg)
Table 43. APAC Human Coagulation Factor VIII Consumption Market Share by Application (2015-2020)
Table 44. Europe Human Coagulation Factor VIII Consumption by Countries (2015-2020) (Kg)
Table 45. Europe Human Coagulation Factor VIII Consumption Market Share by Countries (2015-2020)
Table 46. Europe Human Coagulation Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Human Coagulation Factor VIII Value Market Share by Countries (2015-2020)
Table 48. Europe Human Coagulation Factor VIII Consumption by Type (2015-2020) (Kg)
Table 49. Europe Human Coagulation Factor VIII Consumption Market Share by Type (2015-2020)
Table 50. Europe Human Coagulation Factor VIII Consumption by Application (2015-2020) (Kg)
Table 51. Europe Human Coagulation Factor VIII Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Human Coagulation Factor VIII Consumption by Countries (2015-2020) (Kg)
Table 53. Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Human Coagulation Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Human Coagulation Factor VIII Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Human Coagulation Factor VIII Consumption by Type (2015-2020) (Kg)
Table 57. Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Human Coagulation Factor VIII Consumption by Application (2015-2020) (Kg)
Table 59. Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Application (2015-2020)
Table 60. Human Coagulation Factor VIII Distributors List
Table 61. Human Coagulation Factor VIII Customer List
Table 62. Global Human Coagulation Factor VIII Consumption Forecast by Countries (2021-2025) (Kg)
Table 63. Global Human Coagulation Factor VIII Consumption Market Forecast by Regions
Table 64. Global Human Coagulation Factor VIII Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Human Coagulation Factor VIII Value Market Share Forecast by Regions
Table 66. Global Human Coagulation Factor VIII Consumption Forecast by Type (2021-2025) (Kg)
Table 67. Global Human Coagulation Factor VIII Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Human Coagulation Factor VIII Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Human Coagulation Factor VIII Value Market Share Forecast by Type (2021-2025)
Table 70. Global Human Coagulation Factor VIII Consumption Forecast by Application (2021-2025) (Kg)
Table 71. Global Human Coagulation Factor VIII Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Human Coagulation Factor VIII Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Human Coagulation Factor VIII Value Market Share Forecast by Application (2021-2025)
Table 74. Shire (Baxter) Product Offered
Table 75. Shire (Baxter) Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. Shire (Baxter) Main Business
Table 77. Shire (Baxter) Latest Developments
Table 78. Shire (Baxter) Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 79. Kedrion Product Offered
Table 80. Kedrion Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Kedrion Main Business
Table 82. Kedrion Latest Developments
Table 83. Kedrion Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Product Offered
Table 85. Bayer Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Bayer Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Product Offered
Table 90. Pfizer Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Pfizer Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 94. Grifols Product Offered
Table 95. Grifols Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 96. Grifols Main Business
Table 97. Grifols Latest Developments
Table 98. Grifols Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 99. CSL Product Offered
Table 100. CSL Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 101. CSL Main Business
Table 102. CSL Latest Developments
Table 103. CSL Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 104. NovoNordisk Product Offered
Table 105. NovoNordisk Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 106. NovoNordisk Main Business
Table 107. NovoNordisk Latest Developments
Table 108. NovoNordisk Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 109. Biogen Product Offered
Table 110. Biogen Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Biogen Main Business
Table 112. Biogen Latest Developments
Table 113. Biogen Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 114. Greencross Product Offered
Table 115. Greencross Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 116. Greencross Main Business
Table 117. Greencross Latest Developments
Table 118. Greencross Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 119. Octapharma Product Offered
Table 120. Octapharma Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 121. Octapharma Main Business
Table 122. Octapharma Latest Developments
Table 123. Octapharma Basic Information, Company Total Revenue (in $ million), Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 124. BPL Product Offered
Table 125. BPL Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 126. BPL Main Business
Table 127. BPL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. BPL Latest Developments
Table 129. RAAS Product Offered
Table 130. RAAS Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 131. RAAS Main Business
Table 132. RAAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. RAAS Latest Developments
Table 134. Hualan Bio Product Offered
Table 135. Hualan Bio Human Coagulation Factor VIII Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 136. Hualan Bio Main Business
Table 137. Hualan Bio Latest Developments
Table 138. Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Human Coagulation Factor VIII
Figure 2. Human Coagulation Factor VIII Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Human Coagulation Factor VIII Consumption Growth Rate 2015-2025 (Kg)
Figure 5. Global Human Coagulation Factor VIII Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Recombinant Factor VIII
Figure 7. Product Picture of Plasma-derived Factor VIII
Figure 8. Global Human Coagulation Factor VIII Consumption Market Share by Type (2015-2020)
Figure 9. Global Human Coagulation Factor VIII Value Market Share by Type (2015-2020)
Figure 10. Human Coagulation Factor VIII Consumed in Hemophilia A
Figure 11. Global Human Coagulation Factor VIII Market: Hemophilia A (2015-2020) (Kg)
Figure 12. Global Human Coagulation Factor VIII Market: Hemophilia A (2015-2020) ($ Millions)
Figure 13. Human Coagulation Factor VIII Consumed in Spontanous / Trauma
Figure 14. Global Human Coagulation Factor VIII Market: Spontanous / Trauma (2015-2020) (Kg)
Figure 15. Global Human Coagulation Factor VIII Market: Spontanous / Trauma (2015-2020) ($ Millions)
Figure 16. Human Coagulation Factor VIII Consumed in Surgical
Figure 17. Global Human Coagulation Factor VIII Market: Surgical (2015-2020) (Kg)
Figure 18. Global Human Coagulation Factor VIII Market: Surgical (2015-2020) ($ Millions)
Figure 19. Human Coagulation Factor VIII Consumed in Other
Figure 20. Global Human Coagulation Factor VIII Market: Other (2015-2020) (Kg)
Figure 21. Global Human Coagulation Factor VIII Market: Other (2015-2020) ($ Millions)
Figure 22. Global Human Coagulation Factor VIII Consumption Market Share by Application (2015-2020)
Figure 23. Global Human Coagulation Factor VIII Value Market Share by Application (2015-2020)
Figure 24. Global Human Coagulation Factor VIII Sales Market Share by Company in 2017
Figure 25. Global Human Coagulation Factor VIII Sales Market Share by Company in 2019
Figure 26. Global Human Coagulation Factor VIII Revenue Market Share by Company in 2017
Figure 27. Global Human Coagulation Factor VIII Revenue Market Share by Company in 2019
Figure 28. Global Human Coagulation Factor VIII Sale Price by Company in 2019
Figure 29. Global Human Coagulation Factor VIII Consumption Market Share by Regions 2015-2020
Figure 30. Global Human Coagulation Factor VIII Value Market Share by Regions 2015-2020
Figure 31. Americas Human Coagulation Factor VIII Consumption 2015-2020 (Kg)
Figure 32. Americas Human Coagulation Factor VIII Value 2015-2020 ($ Millions)
Figure 33. APAC Human Coagulation Factor VIII Consumption 2015-2020 (Kg)
Figure 34. APAC Human Coagulation Factor VIII Value 2015-2020 ($ Millions)
Figure 35. Europe Human Coagulation Factor VIII Consumption 2015-2020 (Kg)
Figure 36. Europe Human Coagulation Factor VIII Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Human Coagulation Factor VIII Consumption 2015-2020 (Kg)
Figure 38. Middle East & Africa Human Coagulation Factor VIII Value 2015-2020 ($ Millions)
Figure 39. Americas Human Coagulation Factor VIII Consumption Market Share by Countries in 2019
Figure 40. Americas Human Coagulation Factor VIII Value Market Share by Countries in 2019
Figure 41. Americas Human Coagulation Factor VIII Consumption Market Share by Type in 2019
Figure 42. Americas Human Coagulation Factor VIII Consumption Market Share by Application in 2019
Figure 43. United States Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 44. United States Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 46. Canada Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 48. Mexico Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Human Coagulation Factor VIII Consumption Market Share by Countries in 2019
Figure 50. APAC Human Coagulation Factor VIII Value Market Share by Regions in 2019
Figure 51. APAC Human Coagulation Factor VIII Consumption Market Share by Type in 2019
Figure 52. APAC Human Coagulation Factor VIII Consumption Market Share by Application in 2019
Figure 53. China Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 54. China Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 56. Japan Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 58. Korea Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 60. Southeast Asia Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 61. India Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 62. India Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 64. Australia Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Human Coagulation Factor VIII Consumption Market Share by Countries in 2019
Figure 66. Europe Human Coagulation Factor VIII Value Market Share by Countries in 2019
Figure 67. Europe Human Coagulation Factor VIII Consumption Market Share by Type in 2019
Figure 68. Europe Human Coagulation Factor VIII Consumption Market Share by Application in 2019
Figure 69. Germany Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 70. Germany Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 71. France Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 72. France Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 73. UK Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 74. UK Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 76. Italy Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 78. Russia Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 79. Spain Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 80. Spain Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Human Coagulation Factor VIII Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Human Coagulation Factor VIII Consumption Market Share by Application in 2019
Figure 85. Egypt Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 86. Egypt Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 88. South Africa Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 90. Israel Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 92. Turkey Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Human Coagulation Factor VIII Consumption Growth 2015-2020 (Kg)
Figure 94. GCC Countries Human Coagulation Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 95. Global Human Coagulation Factor VIII Consumption Growth Rate Forecast (2021-2025) (Kg)
Figure 96. Global Human Coagulation Factor VIII Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 98. Americas Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 99. APAC Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 100. APAC Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 101. Europe Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 102. Europe Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 104. Middle East & Africa Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 105. United States Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 106. United States Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 107. Canada Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 108. Canada Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 109. Mexico Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 110. Mexico Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 111. Brazil Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 112. Brazil Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 113. China Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 114. China Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 115. Japan Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 116. Japan Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 117. Korea Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 118. Korea Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 120. Southeast Asia Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 121. India Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 122. India Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 123. Australia Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 124. Australia Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 125. Germany Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 126. Germany Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 127. France Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 128. France Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 129. UK Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 130. UK Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 131. Italy Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 132. Italy Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 133. Russia Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 134. Russia Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 135. Spain Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 136. Spain Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 137. Egypt Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 138. Egypt Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 139. South Africa Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 140. South Africa Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 141. Israel Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 142. Israel Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 143. Turkey Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 144. Turkey Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Human Coagulation Factor VIII Consumption 2021-2025 (Kg)
Figure 146. GCC Countries Human Coagulation Factor VIII Value 2021-2025 ($ Millions)
Figure 147. Shire (Baxter) Human Coagulation Factor VIII Market Share (2018-2020)
Figure 148. Kedrion Human Coagulation Factor VIII Market Share (2018-2020)
Figure 149. Bayer Human Coagulation Factor VIII Market Share (2018-2020)
Figure 150. Pfizer Human Coagulation Factor VIII Market Share (2018-2020)
Figure 151. Grifols Human Coagulation Factor VIII Market Share (2018-2020)
Figure 152. CSL Human Coagulation Factor VIII Market Share (2018-2020)
Figure 153. NovoNordisk Human Coagulation Factor VIII Market Share (2018-2020)
Figure 154. Biogen Human Coagulation Factor VIII Market Share (2018-2020)
Figure 155. Greencross Human Coagulation Factor VIII Market Share (2018-2020)
Figure 156. Octapharma Human Coagulation Factor VIII Market Share (2018-2020)
Figure 157. BPL Human Coagulation Factor VIII Market Share (2018-2020)
Figure 158. RAAS Human Coagulation Factor VIII Market Share (2018-2020)
Figure 159. Hualan Bio Human Coagulation Factor VIII Market Share (2018-2020)


★調査レポート[世界のヒト凝固第VIII因子市場予測 2020年-2025年] (コード:LPI20AP4206)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒト凝固第VIII因子市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆